Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings

Akinci et al.

Med (N Y). 2021 Jul 9;2(7):814-835.

DOI: 10.1016/j.medj.2021.04.001.

https://pubmed.ncbi.nlm.nih.gov/35291351/